Clay Siegall is the current Chief Executive Officer, president and chairman of the board at Seattle Genetics. Clay co-founded Seattle Genetics in 1998. The company deals with scientific innovation, rigorous research, and drug development practices to develop antibody drugs for cancer patients.
Educational background and career achievements
Clay holds a bachelor’s degree in Zoology from the University of Maryland.
He has been the director of the board of directors at Alder Biopharmaceuticals Inc. since 2006 to date. Clay is also the director of the board of directors at Mirna Therapeutics Inc. and Ultragenyx pharmaceutical and among the board of governors at the Fred Hutchinson Research Centre. He previously held a leadership position at National Cancer Institute and Bristol-Myers Squibb Pharmaceutical Research Institute before he co-founded Seattle Genetics.
Clay Siegall’s Contribution in Treating Cancer
Cancer has been the primary cause of deaths in the world. This has made many institutions to come up with drugs to treat and prevent adverse effects of cancer. Among them is Seattle genetics, co-founded by Siegall. Under his leadership, the firm came up with the first FDA-approved antibody-drug conjugate. The Antibody-Drug Conjugate technology used at the firm has been used in other pharmaceuticals to improve on the drug. Clay believes the chemotherapies and radiotherapies will be replaced with tolerable medications that do not have adverse effects on the patients.
The Reason Why Clay Siegall Started Seattle Genetics
Clay had the passion for medicine since childhood, and the desire to intervene the course of nature and restore health in people was something he always wanted to do. He became interested in cancer treatment when studying for zoology. His family member was diagnosed with cancer, and the procedure was brutal and ended up killing the family member. He decided to venture into coming up with a better way to treat cancer apart from the amputation, surgery, and chemotherapies.
Clay Siegall is among the few researchers who have worked hard to see the cure for cancer is found, and people receive better treatments that are not brutal and inhuman.